This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, J. W.
Right arrow Articles by Curtiss, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, J. W.
Right arrow Articles by Curtiss, R., 3rd

 Previous Article  |  Next Article 

J. Bacteriol., Apr 1995, 1703-1711, Vol 177, No. 7
Copyright © 1995, American Society for Microbiology

Purification, characterization, and specificity of dextranase inhibitor (Dei) expressed from Streptococcus sobrinus UAB108 gene cloned in Escherichia coli [published erratum appears in J Bacteriol 1997 Jan;179(2):568]

JW Sun, SY Wanda and R Curtiss 3rd
Department of Biology, Washington University, St. Louis, Missouri 63130, USA.

The dextranase inhibitor gene (dei) from Streptococcus sobrinus UAB108 was previously cloned, expressed, and sequenced. Its gene product (Dei) has now been purified as a single band with apparent molecular mass of 43 kDa, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The specific activity of Dei increased 121-fold upon purification. Most Dei activity (91.2%) was located in the periplasmic fraction from recombinant Escherichia coli cells. Dei competitively inhibits dextranase (Dex). This competitive inhibition mechanism has been further shown by detection and recovery of the intermediate enzyme- inhibitor (Dex-Dei) complex by gel filtration technology using fast protein liquid chromatography. Calibration of their molecular masses indicated that native Dei exists as a tetramer, Dex exists as dimer, and the Dex-Dei complex consists of two Dex molecules with two Dei molecules. Deletion analysis indicates that the intact Dei molecule is essential for Dei activity but not for glucan binding and immune cross- reaction. Dei is a special kind of glucan-binding protein with ability to inhibit Dex with high specificity. It can inhibit endogenous Dex, which can make more branches in glucan with the cooperation of the glucosyltransferase GTF-I. This inhibition cause the accumulation of water-soluble glucan. The latter reaction product can inhibit plaque formation and adherence of the mutans group of streptococcal cells. Dei derived from S. sobrinus UAB108 can inhibit only Dex from S. sobrinus (serotypes d and g), S. downei (previously S. sobrinus, serotype h), and S. macacae (serotype h).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:

  • Khalikova, E., Susi, P., Korpela, T. (2005). Microbial Dextran-Hydrolyzing Enzymes: Fundamentals and Applications. Microbiol. Mol. Biol. Rev. 69: 306-325 [Abstract] [Full Text]  
  • Banas, J.A., Vickerman, M.M. (2003). GLUCAN-BINDING PROTEINS OF THE ORAL STREPTOCOCCI. CROBM 14: 89-99 [Abstract] [Full Text]